Reference : Generation of two human induced pluripotent stem cell lines from fibroblasts of Parki...
Scientific journals : Article
Life sciences : Genetics & genetic processes
http://hdl.handle.net/10993/51824
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)
English
Novak, Gabriela [> >]
Finkbeiner, Steven [> >]
Skibinski, Gaia [> >]
Bernini, Michela mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Integrative Cell Signalling]
Donato, Cristina mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Integrative Cell Signalling]
Skupin, Alexander mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Integrative Cell Signalling]
2022
Stem Cell Resource
61
102765
Yes
[en] Mutations in PINK1 and Parkin are two of the main causes of recessive early-onset Parkinson’s disease (PD). We generated human induced pluripotent stem cells (hiPSCs) from fibroblasts of a 64-year-old male patient with a homozygous ILE368ASN mutation in PINK1, who experienced disease onset at 33 years, and from fibroblasts of a 61-year-old female patient heterozygous for the R275W mutation in Parkin, who experienced disease onset at 44 years. Array comparative genomic hybridization (aCGH) determined genotypic variation in each line. The cell lines were successfully used to generate midbrain dopaminergic neurons, the neuron type primarily affected in PD.
http://hdl.handle.net/10993/51824
10.1016/j.scr.2022.102765
https://www.sciencedirect.com/science/article/pii/S1873506122001143

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
Novak_PINK1_StemCellResour_2022.pdfPublisher postprint1.82 MBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.